Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Improved Prognosis of Treatment Failure in Cervical Cancer with Nontumor PET/CT Radiomics.

Autor: Yusufaly TI; Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, School of Medicine, Baltimore, Maryland; tyusufa2@jhmi.edu., Zou J; Department of Family Medicine and Public Health and Department of Mathematics, University of California San Diego, La Jolla, California., Nelson TJ; Center for Precision Radiation Medicine, La Jolla, California., Williamson CW; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California., Simon A; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California., Singhal M; Center for Precision Radiation Medicine, La Jolla, California., Liu H; Center for Precision Radiation Medicine, La Jolla, California., Wong H; Center for Precision Radiation Medicine, La Jolla, California., Saenz CC; Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, University of California San Diego, La Jolla, California; and., Mayadev J; Center for Precision Radiation Medicine, La Jolla, California.; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California., McHale MT; Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, University of California San Diego, La Jolla, California; and., Yashar CM; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California., Eskander R; Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, University of California San Diego, La Jolla, California; and., Sharabi A; Center for Precision Radiation Medicine, La Jolla, California.; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California., Hoh CK; Department of Radiology, Division of Nuclear Medicine, University of California San Diego, La Jolla, California., Obrzut S; Department of Radiology, Division of Nuclear Medicine, University of California San Diego, La Jolla, California., Mell LK; Center for Precision Radiation Medicine, La Jolla, California.; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California.

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2022 Jul; Vol. 63 (7), pp. 1087-1093. Date of Electronic Publication: 2021 Oct 28.

Positron Emission Tomography-Guided Bone Marrow-Sparing Radiation Therapy for Locoregionally Advanced Cervix Cancer: Final Results From the INTERTECC Phase II/III Trial.

Autor: Williamson CW; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California., Sirák I; Department of Oncology and Radiotherapy, University Hospital, Hradec Kralove, Czech Republic., Xu R; University of California San Diego, La Jolla, California., Portelance L; University of Miami, Miami, Florida., Wei L; Xijing Hospital, Xian, China., Tarnawski R; Marie Sklodowska Cancer Center and Institute of Oncology, Gliwice, Poland., Mahantshetty U; Tata Memorial Centre, Parel, Mumbai, India., Heide ES; University of California Irvine, Irvine, California., Yashar CM; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California., McHale MT; University of California San Diego, La Jolla, California., Bosch W; Department of Radiation Oncology, Washington University in St. Louis, St. Louis, Missouri., Lowenstein J; University of Texas MD Anderson Cancer Center, Houston, Texas., Saenz CC; University of California San Diego, La Jolla, California., Plaxe S; University of California San Diego, La Jolla, California., Eskander R; University of California San Diego, La Jolla, California., Einck J; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California., Mundt AJ; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California., Mayadev J; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California; La Jolla Center for Precision Radiation Medicine, La Jolla, California., Mell LK; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California; La Jolla Center for Precision Radiation Medicine, La Jolla, California. Electronic address: lmell@ucsd.edu.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2022 Jan 01; Vol. 112 (1), pp. 169-178. Date of Electronic Publication: 2021 Aug 20.

Phase 1 Trial of Concurrent Gemcitabine and Cisplatin with Image Guided Intensity Modulated Radiation Therapy for Locoregionally Advanced Cervical Carcinoma.

Autor: Mell LK; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California; Center for Precision Radiation Medicine, La Jolla, California. Electronic address: lmell@ucsd.edu., Xu R; Department of Family Medicine and Public Health and Department of Mathematics, University of California San Diego, La Jolla, California., Yashar CM; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California., McHale MT; Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, University of California San Diego, La Jolla, California., Einck JP; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California., Mayadev J; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California; Center for Precision Radiation Medicine, La Jolla, California., Lee E; Altman Clinical and Translational Research Institute, University of California San Diego, La Jolla, California., Binder P; Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, University of California San Diego, La Jolla, California., Rash D; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California., Eskander R; Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, University of California San Diego, La Jolla, California., Heide ES; Center for Precision Radiation Medicine, La Jolla, California., Plaxe SC; Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, University of California San Diego, La Jolla, California., Mundt AJ; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California; Center for Precision Radiation Medicine, La Jolla, California., Saenz CC; Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, University of California San Diego, La Jolla, California.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Aug 01; Vol. 107 (5), pp. 964-973. Date of Electronic Publication: 2020 Apr 22.